CIK 0001374339
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
ProMIS Neurosciences Inc.
Sign in to watch- Ticker
- PMN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- Operating
- Phone
- +1 416-847-6898
- Business address
- SUITE 200, 1920 YONGE STREET, TORONTO, Ontario, Canada, M4S 3E2
- Former names
- AMORFIX LIFE SCIENCES LTD
- Open-market buys, last 90 days
- $134,746
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$134,746. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Milbury Max A. Principal Accounting Officer | Grant or award · Option (right to buy) | +18,167 | 18,167 | ||
| 2026-02-03 | Milbury Max A. Principal Accounting Officer | Grant or award | +6,595 | $12.13 | $80K | 8,409 |
| 2026-02-03 | Milbury Max A. Principal Accounting Officer | Grant or award · Warrants to purchase Common Shares | +6,595 | 6,595 | ||
| 2025-10-03 | Milbury Max A. Principal Accounting Officer | Purchase | +30,392 | $0.49 | $15K | 45,389 |
| 2025-09-22 | Milbury Max A. Principal Accounting Officer | Grant or award · Option (right to buy) | +60,000 | 60,000 | ||
| 2024-11-18 | Milbury Max A. Principal Accounting Officer | Grant or award · Option (right to buy) | +70,000 | 70,000 | ||
| 2023-10-26 | Milbury Max A. Principal Accounting Officer | Grant or award · Option (right to buy) | +12,500 | 12,500 | ||
| 2023-08-23 | Milbury Max A. Principal Accounting Officer | Grant or award | +13,297 | 14,997 | ||
| 2023-08-23 | Milbury Max A. Principal Accounting Officer | Grant or award · Warrants to purchase Common Shares | +13,297 | 13,297 |
Page 1 of 1 · 9 trades